Contineum Therapeutics, Inc.

CTNM · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.5B · 51 employees
36
SEC Filings
$13.49
Close 2026-05-29
51
Employees

Business Summary

PART I . Overview We are a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of NI&I indications with significant unmet need. We target biological pathways associated with specific clinical impairments that we believe, once modulated, will demonstrably alter the course of disease. We focus on developing selective compounds targeting challenging molecular pathways and have built a portfolio of small molecule drug candidates. We believe our two clinical...

Latest Stock Quote

CTNM 2026-05-29 $13.49 O:$13.36 H:$13.525 L:$13.09 Vol:0.1M VWAP:$13.3907
origin leaf: 02026d299d03c477e1ead819cfa74501d4450273103ef722cf03a8f7ad7b1978

Next Earnings

Q2 FY2026 — expected 2026-09-11

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001628280-26-015165EDGAR96K words
2025-03-062024-12-310001437749-25-006458EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-10-302025-09-300001437749-25-032427EDGAR22K words
2025-08-052025-06-300001437749-25-024852EDGAR—
2025-05-142025-03-310001437749-25-016835EDGAR—
2024-11-062024-09-300001437749-24-033616EDGAR—
2024-08-142024-06-300001437749-24-026680EDGAR—
2024-05-162024-03-310001437749-24-017320EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-050001628280-26-015159EDGAR2K words
2026-01-260001437749-26-002072EDGAR—
2025-12-150001437749-25-037842EDGAR—
2025-12-110001437749-25-037547EDGAR—
2025-11-200001437749-25-035860EDGAR—
2025-10-300001437749-25-032422EDGAR—
2025-09-180001437749-25-029349EDGAR—
2025-08-050001437749-25-024849EDGAR—
2025-06-260001437749-25-021343EDGAR—
2025-05-140001437749-25-016877EDGAR—

36 total filings indexed. 18 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001855175
TickerCTNM
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.contineum-tx.com
Listed2024-04-05

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: fddaf52f151471d875b75bac54e05c84c406830b39e210109e2133e175f9f827
parent: 263bf1d6712c9d0335cf82bdc8f5f59adbf3313ab09b26271b2e76a427def998
content hash: 413fe4d09562693de593e01ba4561619f68837bb563a70cb9283bcbf77907cf2
signed: 2026-06-02T19:00:47.774Z
sources: 9 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf